Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1989;20:1741-1747

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Echiverri, H. C.
Right arrow Articles by Gujrati, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Echiverri, H. C.
Right arrow Articles by Gujrati, M.

Stroke, Vol 20, 1741-1747, Copyright © 1989 by American Heart Association


ARTICLES

Fusiform aneurysm of the vertebrobasilar arterial system

HC Echiverri, FA Rubino, SR Gupta and M Gujrati
Department of Neurology, Hines Veterans Administration Hospital, IL 60141.

We retrospectively evaluated the clinical features and therapeutic outcomes in 13 consecutive patients with the diagnosis of fusiform aneurysm of the vertebrobasilar system. Four patients (31%) presented with compressive symptoms and 10 (77%) with ischemic symptoms; one patient presented with both types of symptoms. No patient presented with rupture of the fusiform aneurysm. Based on the attending physician's choice, treatment included antiplatelet therapy in five patients, anticoagulation in seven, and no medication in one. Five patients died, four treated with antiplatelet agents and one not treated with any medication. The cause of death was progressive brainstem ischemia in three, sepsis in one, and gastrointestinal bleeding in one patient. All seven patients who received anticoagulants were alive, with no recurrence of symptoms or hemorrhagic complications after a mean follow-up period of 18 months. Based on previous and current series, we conclude that rupture of fusiform aneurysms is rare. Our results suggest a more favorable outcome in the management of these aneurysms with anticoagulation therapy to prevent progressive thrombosis and embolization.


This article has been cited by other articles:


Home page
NeurologyHome page
S. G. Passero and S. Rossi
Natural history of vertebrobasilar dolichoectasia
Neurology, January 1, 2008; 70(1): 66 - 72.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
F. Pico, J. Labreuche, I. Gourfinkel-An, P. Amarenco, and on behalf of the GENIC Investigators
Basilar Artery Diameter and 5-Year Mortality in Patients With Stroke
Stroke, September 1, 2006; 37(9): 2342 - 2347.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. G. Passero, B. Calchetti, and S. Bartalini
Intracranial Bleeding in Patients With Vertebrobasilar Dolichoectasia
Stroke, July 1, 2005; 36(7): 1421 - 1425.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. Castelnovo, L. Jomir, A. Le Bayon, S. Bouly, C. Thiebaut, and P. Labauge
Lingual atrophy and dolichoectatic artery
Neurology, October 28, 2003; 61(8): 1121 - 1121.
[Full Text] [PDF]


Home page
StrokeHome page
R. T.F. Cheung, W. Mak, and S. Passero
Two Chinese Patients With Vertebrobasilar Dolichoectasia • Response
Stroke, October 1, 1998; 29(10): 2213 - 2215.
[Full Text]


Home page
StrokeHome page
S. Passero and G. Filosomi
Posterior Circulation Infarcts in Patients With Vertebrobasilar Dolichoectasia
Stroke, March 1, 1998; 29(3): 653 - 659.
[Abstract] [Full Text] [PDF]